Bristol-Myers Spokesperson Says Grade 5 Event That Was Disclosed As Part Of Data Disclosure At MS Toronto Occurred After Trial Pause; Working Closely With FDA To Restart Trial As Soon As Possible, With The Goal Of Resuming Enrollment In Early 2027; Grade 5 Event That Was Disclosed Was Not Related To Our Decision To Pause The BreakFree Program
- Reuters
Share
Why It Matters
Bristol-Myers paused a trial after a serious patient event occurred. The company is working with regulators to restart and resume enrollment in early 2027.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.